-
1
-
-
0029026110
-
-
Goyan JE. Bioequivalence and narrow therapeutic index drugs.
-
Benet LZ, Goyan JE. Bioequivalence and narrow therapeutic index drugs. Pharmacotherapy. 1995;15: 433-440.
-
(1995)
Pharmacotherapy.
, vol.15
, pp. 433-440
-
-
Benet, L.Z.1
-
2
-
-
0028786997
-
-
Dalen JE, DeyKim D
-
Hirsch J, Dalen JE, DeyKim D, et al. Oral anticoagulants: Mechanism of action, clinical effectiveness and optimal therapeutic range. Chest. 1995; 108 (Suppl 6): 231-246.
-
(1995)
Chest.
, vol.108
, Issue.6 SUPPL.
, pp. 231-246
-
-
Hirsch, J.1
-
3
-
-
33847434992
-
-
Rockville, M.D.-23 Convention Inc
-
United States Pharmacopeia. Uniformity of dosing units. Rockville, M.D.-23 Convention Inc; 1995.
-
(1995)
Uniformity of Dosing Units.
-
-
-
4
-
-
0025334006
-
Power of the two one-sided tests procedure in bioequivalence
-
Phillips, K.F. Power of the two one-sided tests procedure in bioequivalence.J. Phannacokin, Biopharm. 1990; 18: 137-144.
-
(1990)
J. Phannacokin, Biopharm.
, vol.18
, pp. 137-144
-
-
Phillips, K.F.1
-
7
-
-
0023914694
-
Medical and economic consequences of blinded oral anticoagulation brand change at a municipal hospital
-
Richton-Hewitt S, Foster E, Apstein CS. Medical and economic consequences of blinded oral anticoagulation brand change at a municipal hospital. A rch Intern Med. 1988;148:806-808.
-
A Rch Intern Med.
, vol.1988
, pp. 806-808
-
-
Richton-Hewitt, S.1
Foster, E.2
Apstein, C.S.3
-
8
-
-
33847444776
-
-
Davis RO, Gagno MA. Drug bioavailability.
-
Ruedy J, Davis RO, Gagno MA. Drug bioavailability. CanMedAssocJ. 1976;! 15:105.
-
CanMedAssocJ. 1976;!
, vol.15
, pp. 105
-
-
Ruedy, J.1
-
10
-
-
0024210974
-
Warfarin bioavailability: A comparison of 6 products
-
Muller FO, Steyn JM, Hundt HK, et al. Warfarin bioavailability: A comparison of 6 products. SAfrMedJ. 1988;76: 11:566-567.
-
(1988)
SAfrMedJ.
, vol.76
, pp. 566-567
-
-
Muller, F.O.1
Steyn, J.M.2
Hundt, H.K.3
-
11
-
-
0018427837
-
Comparison of a new microcrystalline dicoumarol preparation with Warfarin under routine treatment conditions
-
Lockner D, Paul C. Comparison of a new microcrystalline dicoumarol preparation with Warfarin under routine treatment conditions. BrJ Clin Pharmacol. 1979; 8:1:59-64.
-
(1979)
BrJ Clin Pharmacol.
, vol.8
, pp. 59-64
-
-
Lockner, D.1
Paul, C.2
-
12
-
-
0030742078
-
Generic warfarin: Implications for patient care
-
Wittkowsky AK. Generic warfarin: Implications for patient care. Pharmocolherapy. 1997;17:640-643.
-
(1997)
Pharmocolherapy.
, vol.17
, pp. 640-643
-
-
Wittkowsky, A.K.1
-
15
-
-
0028887043
-
Variations in prothrombin time and international normalized ratio over 24 hours in Warfarin treated patients
-
Bleske BE, Welage LS, Warren EW, et al. Variations in prothrombin time and international normalized ratio over 24 hours in Warfarin treated patients. Pharmacotherapy. 1995; 15:709-7012.
-
(1995)
Pharmacotherapy.
, vol.15
, pp. 709-7012
-
-
Bleske, B.E.1
Welage, L.S.2
Warren, E.W.3
-
16
-
-
33847428413
-
-
ANDA submission package to the PDA. Barr Laboratories, Inc. Data on file.
-
ANDA submission package to the PDA. Barr Laboratories, Inc. Data on file.
-
-
-
|